Page 44 - Michael Erman News Today

(Reuters) - Nearly 5.5 million Americans so far have signed up for health insurance for next year through the Affordable Care Act's marketplace, an 18...

By Michael Erman

By Michael Erman NEW YORK (Reuters) - Pfizer Inc is investing more than $2.5 billion at its drug making plants in Belgium and Ireland, gearing up to l...

By Caroline Humer NEW YORK (Reuters) - Moderna Inc's top scientist said on Tuesday that the vaccine maker has learned how to better recruit from diver...

(Reuters) - Merck & Co said on Wednesday Chief Executive Officer Rob Davis would succeed Chairman Ken Frazier, taking on the additional role effective...

By Michael Erman (Reuters) - Merck & Co on Thursday posted better-than-expected third-quarter sales and earnings on a strong performance by its blockb...

(Reuters) - Drugmaker Bristol Myers Squibb said on Tuesday its third-quarter sales fell from last year as generic competition ate into sales of its bl...

Merck & Co said on Wednesday Chief Executive Officer Rob Davis would succeed Chairman Ken Frazier, taking on the additional role effective Dec. 1....

NEW YORK (Reuters) - Pfizer Inc expects to charge about $110 to $130 per dose for its COVID-19 vaccine after the United States government's current pr...

By Michael Erman NEW YORK (Reuters) -Pfizer Inc expects to raise the price of its COVID-19 vaccine to about $110 to $130 per dose after the United Sta...